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Abstract
Purpose: A research was carried out to investigate the incidence of microflora in tablets dispensed from
large container packages used in hospitals and community pharmacies.  It was designed to provide base-
line data on the common biodegrading microorganisms associated with tablets in retail containers and to
highlight the health implications of such observations and roles for pharmacists in self medication
phenomenon in Nigeria. 
Methods: The protocol for the study involved structured selection of representative named
tablets from some public hospitals and community pharmacies within Benin metropolis.
Constitutive microorganisms were elaborated and enumerated using standard microbiological
protocols. 
Results: Our results showed that all the tablets sampled had some form of microbial growth.  However,
aerobic mesophilic bacteria and fungi observed were within standard numerical limits.  It was additionally
observed that ascorbic acid and folic acid tablets, particularly from the community pharmacies failed the
exclusive criteria for Enterobactereacea and Staphylococci.  Tablets from public hospitals in general have
lower incidence of exclusive microbial contamination, compared with community pharmacies.  
Conclusion: Tablets packed in large containers in retail pharmacies in Benin City are often contaminated
with microbial growth. This has possible adverse consequences for those who obtain drugs stored in large
containers.
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Introduction
The microbial quality of pharmaceuticals is
influenced by the environment and quality of
the raw materials used during formulation.
Some infectious outbreaks have been
associated with the use of heavily
contaminated raw materials of natural origin1.
The incidence of microflora in non-sterile
medicines generally is indicated by the nature
of the ingredients (whether natural or
synthetic), the quality of the vehicle and the
care and attitude of personnel involved in their
handling2.
Most raw materials for pharmaceutical
products support some form of microbial
growth, depending on the nutritive properties
and moisture contents.  Hence, dry powder or
tablets are capable of undergoing some form
of microbial spoilage or degradation. The
more serious problem of microbial
contamination of tablets is where there is no
obvious signs of spoilage, hence it is usually
advisable to have knowledge of the microbial
content of all drugs and medicines, whether
they are required to be sterile or non-sterile2.
Manufacturing process for tablets reduces the
viability of microbial cells significantly, hence
microbial growth is rarely observed3.
In tropical countries, pharmaceutical
preparations are frequently stored under
uncontrolled conditions and may be dispensed
in non-protective packaging or even without
any packaging at all, where the average
temperature is 31°C and the average relative
humidity, 75%4, 5.  Dispensing of tablets and
capsules from large packs is a common
practice in hospital pharmacies, clinics,
nursing homes, patent medicine stores.
Some of these packs take an average of 3 –
4 weeks to dispense, depending on the
demands.  In some cases they would take up
to six weeks for such packages like ferrous
salts, folic acid and vitamin B complex. A
study had investigated microbial contents of
some liquid preparations in Nigeria6.  There is
yet no report on the bioburden of tablets in
large dispensing packages or containers
which are common features in hospitals,
clinics, pharmacies and patent medicine
stores.  This could be because of the under
estimation of the health hazards to which
patients are exposed, through the microbial
contamination of such tablets dispensed from
large packages.
The aim of this study is to investigate the
incidence of microflora in tablets dispensed
from large container packages and provide
data on some of the tablet dosage forms
commonly associated with those within the
low socio-economic group of the society in
Benin City, Nigeria. The implications for health
and the central role for pharmacists in bringing
pharmaceutical care to the populace would be
highlighted.
Materials and Methods
Media
Nutrient broth, nutrient agar, MacConkey agar,
Mannitol salt agar, Sabauraud Dextrose agar
were all Oxoid products Oxoid, Basingstoke,
UK).
Preparation of tablet dispersion
Ten (10) tablets each of ascorbic acid,
chloroquine phosphate, paracetamol, folic
acid (Emzor Pharmaceutical Industries Ltd.
Lagos, Nigeria) and film coated ferrous
sulphate (Eupharma Laboratories Ltd, Taluka,
India) were randomly sampled from retail
containers from five (5) community
pharmacies in five different locations in Benin
City.  A similar procedure was adopted for the
same drugs, from retail dispensing packs from
five (5) public hospitals, also in different
locations, within Benin metropolis.
Five (5) tablets each of ascorbic acid,
chloroquine phosphate, ferrous sulphate and
folic acid were dispersed in 10ml sterile
normal saline; while five (5) tablets of
paracetamol were dispersed in 20ml sterile
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normal saline.  Similar procedure, as above
were repeated for samples taken from
unopened fresh containers from both retail
pharmacy outlets and public hospital
pharmacies. Tablet dispersions were mixed in
a vortex mixer for 5 minutes to dislodge
possible microbial cells. The solid particles
sedimented out and the supernatant were
used.
Determination of microbiological quality of
tablets
One millilitre aliquot of each tablet dispersion
was spread on nutrient agar plates,
MacConkey agar plates, mannitol salt agar
plates and Sabauraud dextrose agar plates,
(in duplicates).  The Sabauraud agar plates
were incubated at ambient temperature of
25°C - 27°C, for 72 – 96 h while the other agar
plates were incubated at 37°C for 48 h before
they were observed for growth.  The aerobic
bacteria growth were subjected to further
identification using the protocol of Cowan and
Steel.7 The fungal growth were identified both
microscopically and through the aid of an
Atlas of mycology8.
The total viable aerobic bacterial count (dry
surface plate count method) and the total
viable count for moulds (dry surface plate
count method) as well as the absence (or
presence) of Escherichia coli and
Staphylococcus aureus were assessed as
earlier reported9, 10.
Results and Discussions
The results of the microbiological
examinations of tablets dispensed from large
containers in hospitals and community
pharmacies are shown in Tables 1 and 2,
respectively.  Our result showed that all the
tablets had growth of both aerobic bacteria,
Staphylococci and fungi. The aerobic
organisms were mainly Bacillus species and
Streptococci. The frequent occurrence of
enterobacteriaceae among ascorbic acid and
folic tablets from hospital and community
pharmacies was curiously observed. We also
observed the incidence of Staphylococci
species, most especially among ascorbic acid
and folic acid tablets.  Some Gram-positive
spore-formers were observed with some of
the tablets.  Among the fungi encountered
with the tablets were Microsprum spp,
Penicillium spp, Trichophyton, Aspergillus,
Cephalosporium and Epidermophyton. The
aerobic mesophilic bacteria and fungi were
however within the standard numerical limits
for non-sterile oral preparations like tablets2.
Spoilage of medicines involved basically,
initial or early pioneer invaders of
biodegrading microorganisms, which prepare
the way for later invaders, by degrading
complex nutrients, altering the surrounding pH
and making more moisture available3.  The
microbiological quality, at the moment of
administration of non-sterile pharmaceutical
dosage forms like tablets, is dependent on the
bioburden of the raw materials, both active
drug and excipient11,12, hence the desirability
of observing strictly contamination reduction,
strategy at every stage of production. In an
earlier study, aqueous preparations such as
magnesium trisilicate mixture and kaolin and
morphine mixture, were found to be highly
contaminated6; an observation that has
serious health implications for the consuming
public. Tablets and capsules constitute a large
proportion of the medicines which are
dispensed in modern dispensaries.  Though
many are now presented in blister packs,
situations in most developing countries like
Nigeria still present instances where such
drugs are supplied in bulk packs and the
prescribed amount counted from them.
Mishandling of these drugs in the hands of
untrained personnel could result in serious
health hazards following ingestion of highly
contaminated drugs by patients whose
immunity is already compromised by illness.
It was observed in this study, that most of the
community pharmacies have largely untrained
dispensers, hence the dispensary benches,
spoons, trays are untidily kept.  This practice
coupled with the high level of unhygienic
disposition could have explained the high
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 Table 1: Microbial content of tablets from hospitals 
Values in parenthesis represent counts obtained from unopened control packs 
 
ORIGIN 
(HOSPITAL) 
Total viable 
aerobic count 
(cfu/g) 
Total viable 
count for fungi 
(cfu/g) 
Enterobacteriaceae 
(cfu/g) 
Staph aureus 
(cfu/g) 
 
A Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
B Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
C Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
D Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
E Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
67 (15) 
8 (2) 
9 (2) 
10 (3) 
5 (2) 
 
5 (3) 
3 (2) 
7 (2) 
3 (1) 
8 (3) 
 
9 (2) 
4 (1) 
3 (2) 
1.0 × 102 (3) 
5 (0) 
 
72 (5) 
5 (3) 
3 (2) 
5 (1) 
9 (2) 
 
3 (2) 
9 (1) 
5 (1) 
7 (2) 
4 (2) 
 
5 (4) 
9 (2) 
4 (1) 
3 (2) 
7 (2) 
 
3 (1) 
5 (2) 
9 (1) 
10 (1) 
4 (2) 
 
3 (2) 
5 (1) 
7 (2) 
9 (1) 
5 (2) 
 
0 (1) 
3 (2) 
3 (3) 
8 (1) 
9 (2) 
 
8 (3) 
3 (1) 
8 (2) 
8 (1) 
5 (1) 
 
5 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
 
5 (0) 
0 (0) 
0 (0) 
0 (0) 
7 (0) 
 
5 (0) 
7 (0) 
0 (0) 
4 (0) 
6 (0) 
 
8 (0) 
0 (0) 
0 (0) 
4 (0) 
0 (0) 
 
7 (0) 
0 (0) 
0 (0) 
3 (0) 
0 (0) 
 
40 (2) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
 
11 (1) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
 
4 (2) 
0 (0) 
0 (0) 
8 (1) 
0 (0) 
 
3 (2) 
0 (0) 
0 (0) 
5 (2) 
0 (0) 
 
7 (1) 
0 (0) 
5 (2) 
8 (1) 
6 (1) 
 
 
incidence of Enterobacteriaceae and
Staphylococci species isolated from ascorbic
acid and folic acid tablets from community
pharmacies. 
It was also observed that tablets from public
hospitals appeared to have lower incidence of
microbial contamination, particularly with
respect to Enterobacteriaceae and
Staphylococci species.  This could be due to
less than casual attention to personal hygiene
on the part of dispensers in community
pharmacies, compared with public hospitals.
The expected higher turnover, and hence less
exposure of opened containers, in hospital
settings, could also explain the lower
incidence of Enterobacteriaceae and
Staphylococci species, in public hospitals. It is
pertinent to point out that, in addition to
microbial degradation and spoilage, tablets
like aspirin or penicillins, could cause life-
threatening reactions, when allergic persons
are exposed to very small particles from
mishandling.  It is for these additional reasons
that pharmacists must emphasize to
dispensers, strict observance for accurate
tablet counting with devices, properly cleaned,
before and after use.
Personnel who handle drugs generally and
exposed tablets, in particular, must wear
properly laundered overalls, gloves, face
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 Table 2:   Microbial content of tablets from community pharmacies 
Values in parenthesis represent counts obtained from unopened control packs 
 
ORIGIN (PHARMACY) Total Viable 
aerobic count 
(cfu/g) 
Total viable 
count for fungi 
(cfu/g) 
Enterobacteriaceae 
(cfu/g) 
Staph aureus 
(cfu/g) 
 
Q Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
R Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
X Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
Y Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
Z Ascorbic acid 
 Chloroquine 
 Ferrous (salts) 
 Folic acid 
 Paracetamol 
 
2.5 × 102 (12) 
5 (2) 
3 (1) 
2.5 × 102 (4) 
7 (2) 
 
1.0 × 102 (4) 
10 (1) 
7 (1) 
1.0 × 101 (2) 
5 (0) 
 
1.0 × 102 
3 (1) 
7 (2) 
10 (1) 
5 (0) 
 
1.0 × 102 
6 (0) 
3 (1) 
9 (0) 
3 (1) 
 
7 (0) 
3 (0) 
9 (0) 
10 (2) 
5 (0) 
 
1.5 × 102 (3) 
6 (1) 
5 (1) 
3 (0) 
9 (0) 
 
7 (0) 
5 (0) 
3 (0) 
9 (1) 
2 (1) 
 
10 (1) 
7 (0) 
5 (0) 
3 (0) 
9 (0) 
 
9 (0) 
5 (2) 
5 (3) 
3 (3) 
7 (0) 
 
5 (1) 
3 (0) 
3 (0) 
5 (0) 
3 (0) 
 
10 (0) 
0 (0) 
0 (0) 
10 (0) 
0 (0) 
 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
2 (0) 
 
7 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
 
8 (3) 
0 (0) 
0 (0) 
4 (0) 
6 (0) 
 
0 (0) 
0 (0) 
0 (0) 
5 (0) 
0 (0) 
 
0 (0) 
0 (0) 
0 (0) 
2 (0) 
5 (0) 
 
1 × 102 (2) 
0 (0) 
1 × 102 (2) 
3 (0) 
7 (1) 
 
8 (1) 
5 (1) 
3 (2) 
5 (2) 
0 (0) 
 
8 (1) 
3 (1) 
0 (0) 
9 (2) 
0 (0) 
 
6 (1) 
0 (0) 
9 (1) 
3 (2) 
0 (0) 
 
masks, to exclude excessive droplets from
nasal passage and buccal cavity, that are
generally associated with sneezing, coughing
or talking. Hand washing facilities must in
addition be available and usable. Above all,
more cheaply designed multi-dose packs
which dispense tablets individually through a
shutter release aperture, without having to
open the container cover would ultimately
revolutionize large package dispensing.
The study has highlighted the microbial
contamination level of tablets dispensed from
retail packs from both public and community
pharmacies.  Ascorbic acid and folic acid
tablets mainly from community pharmacies
were contaminated with Staphylococci  spps
and Enterobacteriaceae, which are included in
the exclusive criteria for non-sterile oral
formulations.  Strict observance of dispensing
guidelines would reduce the bioburden of
retain dispensing and the associated health
hazards.
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